检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:陈玮[1] 张志清[1] 贡莹[1] 何文娟[1] 韩玉冰[1]
出 处:《中国药房》2014年第21期1937-1939,共3页China Pharmacy
基 金:2011年河北省自然科学基金资助项目(No.C2011206186)
摘 要:目的:考察奥拉西坦对肝微粒体酶CYP2C9活性的影响。方法:将大鼠随机分为对照组和实验组,每组18只,对照组每天灌胃蒸馏水,实验组每天灌胃奥拉西坦80 mg/kg,每日2次,连续8 d。第8天灌胃后两组大鼠均立即灌胃给予CYP2C9的探针药物甲苯磺丁脲50 mg/kg,并于给予甲苯磺丁脲后0.25、0.5、0.75、1、1.5、2、3、4、6、10、12、24 h内眼内眦取血。采用高效液相色谱法测定血药浓度,拟合药动学参数,并对两组药动学参数进行比较。结果:对照组与实验组主要药动学参数t1/2分别为(5.45±1.98)、(6.54±1.45)h,cmax分别为(169.12±58.14)、(146.19±49.44)mg/L,AUC0-24 h分别为(1 113.01±264.32)、(1 120.14±208.91)mg·h/L,Vd分别为(0.77±0.32)、(0.91±0.40)L/kg,CL分别为(0.08±0.03)、(0.08±0.02)L/(h·kg),两组间比较差异无统计学意义(P>0.05)。结论:奥拉西坦对甲苯磺丁脲在大鼠体内的药动学未见明显影响,初步认为奥拉西坦对经CYP2C9代谢的药物的药动学无明显影响。OBJECTIVE:To investigate the effects of oxiracetam on the activity of hepatomicrosome enzyme CYP2C9.METHORDS:Rats were randomly divided into control group and test group with 18 rats in each group.Control group was given distilled water intragastrically,while test group was given oxiracetam(80 mg/kg)intragastrically,twice a day,for consecutive 8 d.Both groups were given hepatomicrosome enzyme CYP2C9 probe tolbutamide(50 mg/kg)intragastrically on the eighth day immediately after gavage;the blood samples were collected from epicanthal folds within 0.25,0.5,0.75,1,1.5,2,3,4,6,10,12,24 h after tolbutamide.The blood concentrations of tolbutamide were determined by HPLC.The pharmacokinetic parameters of the two groups were calculated and compared.RESULTS:The main pharmacokinetic parameters of control group and test group were as follows:t1/2were(5.45±1.98)h vs.(6.54±1.45)h;cmax:(169.12±58.14)mg/L vs.(146.19±49.44)mg/L;AUC0-24 h:(1 113.01±264.32)mg·h/L vs.(1 120.14±208.91)mg·h/L;Vd:(0.77±0.32)L/kg vs.(0.91±0.40)L/kg;CL:(0.08±0.03) L/(h·kg)vs.(0.08±0.02)L/(h·kg).There was no significant difference between 2 groups(P〉0.05).CONCLUSIONS:The pharmacokinetics of tolbutamide in rats has no significant change after treated with oxiracetam;it is preliminary considered that oxiracetam has no obvions effect on the products metabolized by CYP2C9.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.90